biostudies-literatureUnknown32(3)Zuckerman AD<h4>Background</h4>Though specialty pharmacies collect and report a myriad of measures to internal and external stakeholders, these data are infrequently used for evaluating specialty pharmacy performance or clinical decision-making. Establishing standardized specialty pharmacy measures could enable benchmarking, performance-based contracting, and high-cost drug utilization management while improving patient care and specialty medication management.<h4>Objective</h4>To determine consensus among specialty pharmacy stakeholders on important and usable measures for specialty pharmacies managing patients with rheumatoid arthritis (RA).<h4>Methods</h4>A modified Delphi study was conducted with a multisite study group (n = 25 sites). Expert panelists from diverse RA-related backgrounds participaJournal of managed care & specialty pharmacy360-373https://www.ebi.ac.uk/biostudies/studies/S-EPMC12948757biostudies-literatureFinding consensus on meaningful reporting measures for rheumatoid arthritis: Results from a modified Delphi study.PMC12948757Plaia GStutsky MGazda NPO'Reilly EAChoi LDornbush NLDeClercq JVest MHLiang DLopez-Medina AISimonson DRector ABrown MSt James GZuckerman ADThomas KCCostigan BfalseFinding consensus on meaningful reporting measures for rheumatoid arthritis: Results from a modified Delphi study.<h4>Background</h4>Though specialty pharmacies collect and report a myriad of measures to internal and external stakeholders, these data are infrequently used for evaluating specialty pharmacy performance or clinical decision-making. Establishing standardized specialty pharmacy measures could enable benchmarking, performance-based contracting, and high-cost drug utilization management while improving patient care and specialty medication management.<h4>Objective</h4>To determine consensus among specialty pharmacy stakeholders on important and usable measures for specialty pharmacies managing patients with rheumatoid arthritis (RA).<h4>Methods</h4>A modified Delphi study was conducted with a multisite study group (n = 25 sites). Expert panelists from diverse RA-related backgrounds participa2026-01-01T00:00:00Z2026 Mar2026-07-16T23:24:42.898Z2026-07-12T03:11:18.276ZS-EPMC129487574176056410.18553/jmcp.2026.32.3.360